Skip to Content

NVR RIC (Kisqali 200 mg)

Generic Name: ribociclib

Pill with imprint NVR RIC is Purple, Round and has been identified as Kisqali 200 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Kisqali is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug class CDK 4/6 inhibitors. Kisqali 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for NVR RIC

Kisqali

Generic Name:
ribociclib
Imprint:
NVR RIC
Strength:
200 mg
Color:
Purple
Shape:
Round
Availability:
Prescription only
Drug Class:
CDK 4/6 inhibitors
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals Corporation
National Drug Code (NDC):
00078-0874

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide